Boehringer Ingelheim's Jascayd (nerandomilast) has received a positive CHMP opinion the first selective PDE4B inhibitor in pulmonary fibrosis
Many employers have been slow to add coverage for anti-obesity medications to their health plans, viewing them as "lifestyle" drugs despite the FDA's classification of obesity as a chronic disease
Makowski was featured in an article for Nature Reviews Cancer called Are GLP-1 receptor antagonists a magic bullet for cancer? Very little is known, but what were discovering is that it changes lots of different factors that circulate in our blood and that we think are going to affect your immune system, said Makowski
Piccinini, L
Thus, mutations that significantly impair the function of the enzyme cause VLCADD
While each of these compounds offers unique benefits on its own, when combined in a clinically researched formula like 2nd Springs ALA + ALC Complex they become a synergistic duo that works at the core of your cells to support foundational health: energy production, antioxidant defense, and mental sharpness
